- Corporate Officers - S
- Schilke Tobin
Insider Trading History of Schilke Tobin
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schilke Tobin since 2017.
This trader's CIK number is 1678984.
At the time of last reporting, Schilke Tobin was the Chief Financial Officer of Crinetics Pharmaceuticals, Inc.. (stock ticker symbol CRNX).
Also see all insider trading activities at Crinetics Pharmaceuticals, Inc..
Note that in the past
Schilke Tobin also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Crinetics Pharmaceuticals, Inc. (CRNX) by Schilke Tobin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | CRNX | 0 | $0 | 6,713 | $266,304 | 0 | $0 |
Yearly summary of insider trading at Achaogen, Inc. (AKAO) by Schilke Tobin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | AKAO | 0 | $0 | 3,493 | $39,618 | 0 | $0 |
| 2017 | AKAO | 0 | $0 | 3,021 | $60,504 | 0 | $0 |
Yearly summary of insider trading at Revance Therapeutics, Inc. (RVNC) by Schilke Tobin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | RVNC | 0 | $0 | 9,361 | $47,207 | 0 | $0 |
| 2023 | RVNC | 0 | $0 | 65,526 | $2,123,556 | 0 | $0 |
Insider trading activities at 3 companies by Schilke Tobin:
1. Crinetics Pharmaceuticals, Inc. (CRNX)
2. Achaogen, Inc. (AKAO)
3. Revance Therapeutics, Inc. (RVNC)
Table 1. Insider trading of Crinetics Pharmaceuticals, Inc. (CRNX) by Schilke Tobin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-03-03 | CRNX | Sale | 6,713 | 39.67 | 266,304 |
Table 2. Insider trading of Achaogen, Inc. (AKAO) by Schilke Tobin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-06-26 | AKAO | Sale | 298 | 9.59 | 2,857 |
| 2018-06-11 | AKAO | Sale | 2,087 | 11.95 | 24,939 |
| 2018-02-21 | AKAO | Sale | 1,108 | 10.67 | 11,822 |
| 2017-06-12 | AKAO | Sale | 2,066 | 21.53 | 44,480 |
| 2017-01-26 | AKAO | Sale | 955 | 16.78 | 16,024 |
Table 3. Insider trading of Revance Therapeutics, Inc. (RVNC) by Schilke Tobin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-03-18 | RVNC | Sale | 9,361 | 5.04 | 47,207 |
| 2023-07-03 | RVNC | Sale | 1,701 | 25.04 | 42,593 |
| 2023-06-01 | RVNC | Sale | 2,701 | 30.57 | 82,569 |
| 2023-06-02 | RVNC | Sale | 500 | 31.00 | 15,500 |
| 2023-05-15 | RVNC | Sale | 21,401 | 34.55 | 739,340 |
| 2023-05-01 | RVNC | Sale | 3,201 | 31.70 | 101,471 |
| 2023-04-03 | RVNC | Sale | 3,201 | 32.15 | 102,912 |
| 2023-04-03 | RVNC | Sale | 3,201 | 32.15 | 102,912 |
| 2023-03-09 | RVNC | Sale | 18,517 | 31.59 | 584,877 |
| 2023-03-01 | RVNC | Sale | 3,201 | 33.50 | 107,233 |
| 2023-02-01 | RVNC | Sale | 3,201 | 34.60 | 110,754 |
| 2023-01-20 | RVNC | Sale | 1,000 | 31.00 | 31,000 |
| 2023-01-09 | RVNC | Sale | 3,701 | 27.67 | 102,395 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Schilke Tobin
(Chief Financial Officer of Crinetics Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.